It was understood. Vaccines would be the answer to the Covid-19 pandemic that erupted in late 2019 in China. Helped by States, the laboratories developed several versions in record time. Therefore, it was necessary not only to produce them in mass, but also to ensure their distribution to the four corners of the world. It is in this context that the Covax system was born with the objective of facilitating access to vaccines in poor countries.